Spineart Sa

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$12Mgeneral payments (2019-2025)
$507Kresearch payments (2019-2025)
130clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $1.1M
2020 $1.2M
2021 $1.4M
2022 $1.6M
2023 $1.9M
2024 $2.0M
2025 $2.5M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Orthopaedic Surgery of The Spine $5.6M
Orthopaedic Surgery $3.2M
Neurological Surgery $2.7M
Surgery $104K
Otolaryngology $95K
Child & Adolescent Psychiatry $1,023

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Stacey Bederman Orange, CA Orthopaedic Surgery of The Spine $1,843,059.88
Alan Daniels East Providence, RI Orthopaedic Surgery $1,249,811.32
Connor Telles Fresno, CA Orthopaedic Surgery $1,007,281.00
Warren Yu Washington, DC Orthopaedic Surgery of The Spine $731,725.55
Jeffrey Deckey Orange, CA Orthopaedic Surgery of The Spine $651,601.00
Richard Meyrat Dallas, TX Neurological Surgery $612,503.89
Mudit Sharma Manassas, VA Neurological Surgery $530,650.16
Mohammad Majd New Albany, IN Orthopaedic Surgery of The Spine $474,027.00
Vivek Kushwaha Houston, TX Orthopaedic Surgery of The Spine $426,316.00
Raed Ali Fullerton, CA Orthopaedic Surgery $365,640.00

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.